Literature DB >> 9409660

Human peripheral eosinophils express functional interferon-gamma receptors (IFN-gammaR).

C Ishihara1, K Ochiai, M Kagami, H Takashahi, G Matsuyama, S Yoshida, H Tomioka, N Koya.   

Abstract

In order to determine whether or not IFN-gammaR is associated with regulatory mechanisms on human eosinophil function, we examined the expression of functional IFN-gammaR on human peripheral eosinophils. In this study, peripheral blood eosinophils were obtained from seven normal controls and 12 patients (bronchial asthma, n = 9, and hypereosinophilic syndrome (HES), n = 3), and the purity of eosinophils was 97.11 +/- 2.31%, n = 19. We first showed that anti-IFN-gammaR alpha-chain MoAb reacted with all tested eosinophils of both normal controls and patients by flow cytometry analysis. We also showed expression of mRNA for the alpha-chain of IFN-gammaR in all purified eosinophils of six individuals. Further, to characterize IFN-gammaR on eosinophils, we did binding experiments with 125I-IFN-gamma on purified peripheral eosinophils. The linear Scatchard plot indicated a single type of high-affinity binding sites (dissociation constant (Kd) = 3.89-4.95 x 10(-10) M, numbers of binding sites = 183-233/cell, n = 3). To determine whether IFN-gammaR on eosinophils is functional, we examined surface eosinophilic cationic protein (ECP) and CD69 induction after IFN-gammaR ligation with recombinant human IFN-gamma (rhIFN-gamma) on eosinophils by flow cytometry. rhIFN-gamma stimulation significantly induced both ECP and CD69 expression on the 2-18 h-cultured eosinophils in a dose-dependent manner. Further, the effects of rhIFN-gamma stimulation were significantly blocked by both a neutralizing anti-IFN-gamma MoAb and a blocking anti-IFN-gammaR MoAb. These results suggest that human peripheral eosinophils express functional IFN-gammaR.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409660      PMCID: PMC1904819          DOI: 10.1046/j.1365-2249.1997.4511469.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

1.  Airway IFN-γ production during RSV bronchiolitis is associated with eosinophilic inflammation.

Authors:  Chang Keun Kim; Zak Callaway; Young Yull Koh; Soo-Hee Kim; Takao Fujisawa
Journal:  Lung       Date:  2011-12-13       Impact factor: 2.584

2.  Role of JAK2 signal transductional pathway in activation and survival of human peripheral eosinophils by interferon-gamma (IFN-gamma).

Authors:  K Ochiai; E Tanabe; C Ishihara; M Kagami; T Sugiyama; M Sueishi; N Koya; H Tomioka
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  Replenishment of RANTES mRNA expression in activated eosinophils from atopic asthmatics.

Authors:  J R Velazquez; P Lacy; R Moqbel
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

4.  Increases in airway eosinophilia and a th1 cytokine during the chronic asymptomatic phase of asthma.

Authors:  Chang Keun Kim; Jungi Choi; Zak Callaway; Koji Iijima; Gerald Volcheck; Hirohito Kita
Journal:  Respir Med       Date:  2010-08-14       Impact factor: 3.415

5.  The effect of interleukin-18 on airway inflammation in asthmatic murine models and its mechanisms.

Authors:  Huilan Zhang; Zhenxiang Zhang; Yongjian Xu; Lihua Xing; Jianbo Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-10

6.  Prenatal exposure to allergen, DNA methylation, and allergy in grandoffspring mice.

Authors:  M Niedzwiecki; H Zhu; L Corson; G Grunig; P H Factor; S Chu; H Jiang; R L Miller
Journal:  Allergy       Date:  2012-05-14       Impact factor: 13.146

7.  Relationships between Cytokine Profiles and Signaling Pathways (IκB Kinase and p38 MAPK) in Parainfluenza Virus-Infected Lung Fibroblasts.

Authors:  Masakazu Yoshizumi; Hirokazu Kimura; Yoshimichi Okayama; Atsuyoshi Nishina; Masahiro Noda; Hiroyuki Tsukagoshi; Kunihisa Kozawa; Masahiko Kurabayashi
Journal:  Front Microbiol       Date:  2010-11-15       Impact factor: 5.640

Review 8.  Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity.

Authors:  Francis Davoine; Paige Lacy
Journal:  Front Immunol       Date:  2014-11-10       Impact factor: 7.561

9.  The anti-parasitic drug miltefosine suppresses activation of human eosinophils and ameliorates allergic inflammation in mice.

Authors:  Eva Knuplez; Melanie Kienzl; Athina Trakaki; Rudolf Schicho; Akos Heinemann; Eva M Sturm; Gunther Marsche
Journal:  Br J Pharmacol       Date:  2021-02-02       Impact factor: 9.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.